Oriflame Holding AG said its fourth-quarter normalized net income amounted to 39 euro cents per share, compared with the S&P Capital IQ consensus estimate of 35 cents per share.
EPS fell year over year from 39 cents.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was €21.4 million, a decline from €21.9 million in the prior-year period.
The normalized profit margin increased to 6.3% from 6.2% in the year-earlier period.
Total revenue declined on an annual basis to €339.5 million from €353.7 million, and total operating expenses declined year over year to €297.3 million from €312.3 million.
Reported net income grew from the prior-year period to €9.1 million, or 16 cents per share, from €3.5 million, or 6 cents per share.
For the year, the company's normalized net income totaled 87 cents per share, compared with the S&P Capital IQ consensus normalized EPS estimate of 81 cents.
EPS declined 11.6% from 99 cents in the prior year.
Normalized net income was €48.1 million, a decrease of 12.9% from €55.2 million in the prior year.
Full-year total revenue declined on an annual basis to €1.21 billion from €1.27 billion, and total operating expenses fell year over year to €1.11 billion from €1.16 billion.
The company said reported net income decreased 8.8% year over year to €34.2 million, or 62 cents per share, in the full year, from €37.5 million, or 67 cents per share.